Results 191 to 200 of about 7,774 (200)

Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)

European Journal of Medicinal Chemistry, 2020
Minhang Xin, Hao Zhang, Hong-Yi Zhao
exaly  

Proteolysis Targeting Chimeras (PROTACs) Based on Imatinib Induced Degradation of BCR-ABL in K562 Cells

ChemistrySelect, 2023
Feng Sang, Yuting Cui, Bingxia Sun
exaly  

Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC)

Biochemical and Biophysical Research Communications, 2018
Chi Hoon Park, Chung Hyo Kang, Jong Yeon Hwang   +2 more
exaly  

Proteolysis-targeting Chimeras for Targeting Protein for Degradation

Future Medicinal Chemistry, 2019
Gang Zhang, Jianguo Qi
exaly  

Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)

European Journal of Medicinal Chemistry, 2020
Frank J Dekker, Deng Chen, Fangyuan Cao
exaly  

Chemically induced degradation of CK2 by proteolysis targeting chimeras based on a ubiquitin–proteasome pathway

Bioorganic Chemistry, 2018
Shaohua Gou, Nannan Liu
exaly  

Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506-Binding Protein 51 (FKBP51)

Angewandte Chemie - International Edition
Frederik Lermyte, Christian Meyners, Felix Hausch   +2 more
exaly  

Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment

International Journal of Biological Macromolecules
Xupeng Mu, Weifang Tong
exaly  

Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy

International Journal of Nanomedicine
Xiaoling Xu
exaly  

Self-Assembled Peptide-Derived Proteolysis-Targeting Chimera (PROTAC) Nanoparticles for Tumor-Targeted and Durable PD-L1 Degradation in Cancer Immunotherapy

Angewandte Chemie - International Edition
Joon Kyung Seong, Kwangmeyung Kim, Yongju Kim   +2 more
exaly